| # | Drug | Count |
|---|---|---|
| 0 | PANTOPRAZOLE | 36 |
| 1 | ADALIMUMAB | 33 |
| 2 | DEXAMETHASONE | 26 |
| 3 | DEXAMETHASONE 1.5 MG | 26 |
| 4 | NAPROXEN SODIUM | 26 |
| 5 | DICLOFENAC | 25 |
| 6 | DICLOFENAC SODIUM | 25 |
| 7 | FLUOXETINE HYDROCHLORIDE | 25 |
| 8 | NAPROXEN | 24 |
| 9 | ONDANSETRON HYDROCHLORIDE | 24 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | AMCINONIDE | 1 | 0.0118 |
| 1 | METHENAMINE, SODIUM PHOSPHATE, MONOBASIC, METHYLENE BLUE, AND HYOSCYAMINE SULFATE | 1 | 0.0090 |
| 2 | AMIKACIN SULFATE | 14 | 0.0080 |
| 3 | BAXDROSTAT | 2 | 0.0073 |
| 4 | HALOPERIDOL DECANOATE | 4 | 0.0023 |
| 5 | SEVOFLURANE | 18 | 0.0021 |
| 6 | HUMAN CYTOMEGALOVIRUS IMMUNE GLOBULIN | 1 | 0.0021 |
| 7 | CHLORZOXAZONE | 2 | 0.0015 |
| 8 | BETAXOLOL | 1 | 0.0012 |
| 9 | DICLOXACILLIN SODIUM | 1 | 0.0011 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 78 |
| 1 | Corticosteroid [EPC] | 73 |
| 2 | Angiotensin 2 Receptor Blocker [EPC] | 42 |
| 3 | Proton Pump Inhibitor [EPC] | 28 |
| 4 | Factor Xa Inhibitor [EPC] | 27 |
| 5 | Thalidomide Analog [EPC] | 27 |
| 6 | beta-Adrenergic Blocker [EPC] | 27 |
| 7 | Kinase Inhibitor [EPC] | 26 |
| 8 | Dihydropyridine Calcium Channel Blocker [EPC] | 24 |
| 9 | HMG-CoA Reductase Inhibitor [EPC] | 24 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 1 | 4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC] | 1 | 0.0012 |
| 2 | Endoglycosidase [EPC] | 2 | 0.0011 |
| 3 | Provitamin D2 Compound [EPC] | 21 | 0.0007 |
| 4 | Sympathomimetic-like Agent [EPC] | 22 | 0.0007 |
| 5 | Sodium Channel Blocker [EPC] | 1 | 0.0006 |
| 6 | CD38-directed Cytolytic Antibody [EPC] | 3 | 0.0005 |
| 7 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 8 | General Anesthetic [EPC] | 19 | 0.0004 |
| 9 | Soluble Guanylate Cyclase Stimulator [EPC] | 12 | 0.0004 |